BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27666321)

  • 21. Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review.
    Laszlo HE; Seward E; Ayling RM; Lake J; Malhi A; Stephens C; Pritchard-Jones K; Chung D; Hackshaw A; Machesney M
    Br J Cancer; 2022 Mar; 126(5):736-743. PubMed ID: 34903843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of multiple loading FIT sample collection devices on faecal haemoglobin concentration.
    John C; Piggott C; Benton SC
    Ann Clin Biochem; 2024 Jan; 61(1):70-73. PubMed ID: 37285548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.
    Westwood M; Lang S; Armstrong N; van Turenhout S; Cubiella J; Stirk L; Ramos IC; Luyendijk M; Zaim R; Kleijnen J; Fraser CG
    BMC Med; 2017 Oct; 15(1):189. PubMed ID: 29061126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low faecal haemoglobin concentration potentially rules out significant colorectal disease.
    McDonald PJ; Digby J; Innes C; Strachan JA; Carey FA; Steele RJ; Fraser CG
    Colorectal Dis; 2013 Mar; 15(3):e151-9. PubMed ID: 23199241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients.
    Maclean W; Mackenzie P; Limb C; Zahoor Z; Whyte MB; Rockall T; Benton SC; Jourdan I
    Colorectal Dis; 2021 Sep; 23(9):2376-2386. PubMed ID: 34157205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
    Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
    Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A service evaluation of the use of faecal immunochemical tests in symptomatic patients aged under 50 years presenting to primary care.
    Tibbs RE; Benton SC
    Ann Clin Biochem; 2024 Jan; 61(1):48-54. PubMed ID: 37414413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
    Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
    Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
    Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the analytical performance of point-of-care faecal immunochemical tests for haemoglobin.
    O'Driscoll S; Carroll M; Maclean W; Piggott C; Jourdan I; Benton SC
    Ann Clin Biochem; 2021 May; 58(3):181-189. PubMed ID: 33353372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations.
    Fraser CG; Benton SC
    Clin Chem Lab Med; 2019 Apr; 57(5):611-616. PubMed ID: 29995629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
    Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
    BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
    Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J
    BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care.
    Johnstone MS; MacLeod C; Digby J; Al-Azzawi Y; Pang G; Watson AJM; Strachan J; Mowat C; McSorley ST
    Colorectal Dis; 2022 Dec; 24(12):1498-1504. PubMed ID: 35776684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.
    Grazzini G; Ventura L; Rubeca T; Rapi S; Cellai F; Di Dia PP; Mallardi B; Mantellini P; Zappa M; Castiglione G
    Eur J Cancer Prev; 2017 Jul; 26(4):285-291. PubMed ID: 27271031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.